CCL13 (MCP-4) has been implicated in inflammatory processes in asthma (34, 35), and CCL17 (TARC) is a biomarker of atopic dermatitis severity with a reported case of transient increase after FIA (36). This evidence concerns the gene CCL17 and atopic eczema.